7th Metabolic Continuum Roundtable™ Annual Meeting – Steatotic Liver Disease (MASLD/MASH): Disease Burden – Patient Reported Outcomes – Health Economics: Payor & Societal Perspectives
November 10, 2023, | Boston, MA
Contact Us »

6th NASH Roundtable™ Forum – Clinical Trials with Non-Invasive Tests (NITs) Instead of Histology: Fact or Fancy?
November 5, 2022 | Washington, DC
More information »

5th NASH Roundtable™ Virtual Forum – Is Digital Pathology a Game-Changer for Histology for NASH Drug Development?
June 16, 2022 | Virtual
More information »


Fact Sheet: Metabolic Continuum Roundtable™, leading clinical development experts addressing challenges in NASH drug development

View Fact Sheet »

Member Co-authored Publications

November 21, 2023

A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease. Read More »

October 30, 2023

Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score. Read More »

October 23, 2023

Digital pathology and artificial intelligence in non-alcoholic steatohepatitis: current status and future directions. Read More »

October 3, 2023

Digital pathology for nonalcoholic steatohepatitis assessment. Read More »